Erectile dysfunction following Nd-YAG visual laser-assisted prostatectomy (VLAP)

Area of Science:

• Urology
• Andrology
• Laser Surgery

Background:

• Erectile dysfunction (ED) is a common concern following prostate surgery.
• Visual laser prostatectomy (VLAP) is a treatment option for benign prostatic hyperplasia (BPH).

Purpose of the Study:

• To investigate the incidence of new-onset ED after VLAP in sexually active men.
• To identify potential risk factors associated with VLAP-induced ED.

Main Methods:

• Prospective study of 36 sexually active men undergoing VLAP.
• Detailed medical and sexual history, physical examination, and laboratory tests.
• Post-operative assessment included pudendal nerve conduction (PNC), Doppler ultrasonography, and nocturnal penile tumescence (NPT/RigiScan) testing for new-onset ED.

Main Results:

• 16.7% (6/36) of patients developed significant post-operative ED.
• A trend towards higher energy application and longer lasing times was observed in patients with ED.
• No correlation found between prostate size or coagulation site and ED.
• Associated symptoms included loss of erections, retrograde ejaculation, and decreased orgasmic sensation.
• Abnormal results in PNC, Doppler, and NPT/RigiScan were noted in affected patients.

Conclusions:

• VLAP may be associated with a higher-than-expected rate of erectile dysfunction.
• Lasing time and applied laser energy intensity appear to be potential contributing factors to post-VLAP ED.
• Further research is warranted to confirm these findings and optimize VLAP techniques to minimize ED risk.